Market Research Logo

Lung Cancer Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

Lung Cancer Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

The report on global lung cancer therapeutics market provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global lung cancer therapeutics market to grow with a CAGR of 12.50% over the forecast period of 2018-2024. The study on lung cancer therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.
The report on lung cancer therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global lung cancer therapeutics market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global lung cancer therapeutics market over the period of 2016 to 2024. Further, IGR- Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global lung cancer therapeutics market is segmented on the basis of type of molecule and disease type.

Global Lung Cancer Therapeutics Market by Type of Molecule
 Small Molecules
 Biologics

Global Lung Cancer Therapeutics Market by Disease Type
 NSCLC
 SCLC

Company Profiles
 Astellas Pharma
 Pfizer
 Amgen
 Celgene
 AstraZeneca
 F. Hofmann-La Roche
 GlaxoSmithKline
 Aetna, Agennix
 Eli Lilly
 Boston Biomedical

How this report delivers?
1. Comprehensive analysis of global as well as regional markets of lung cancer therapeutics market.
2. Complete coverage of all the segments in lung cancer therapeutics market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in global lung cancer therapeutics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.


The report on lung cancer therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global lung cancer therapeutics market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Global Lung Cancer Therapeutics Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.5. Competitive Landscape in the Global Lung Cancer Therapeutics Market
4. Global Lung Cancer Therapeutics Market by Type of Molecule
4.1. Small Molecules
4.2. Biologics
5. Global Lung Cancer Therapeutics Market by Disease Type
5.1. NSCLC
5.2. SCLC
6. Global Lung Cancer Therapeutics Market by Region 2018-2024
6.1. North America
6.1.1. North America Lung Cancer Therapeutics Market by Type of Molecule
6.1.2. North America Lung Cancer Therapeutics Market by Disease Type
6.1.3. North America Lung Cancer Therapeutics Market by Country
6.2. Europe
6.2.1. Europe Lung Cancer Therapeutics Market by Type of Molecule
6.2.2. Europe Lung Cancer Therapeutics Market by Disease Type
6.2.3. Europe Lung Cancer Therapeutics Market by Country
6.3. Asia-Pacific
6.3.1. Asia-Pacific Lung Cancer Therapeutics Market by Type of Molecule
6.3.2. Asia-Pacific Lung Cancer Therapeutics Market by Disease Type
6.3.3. Asia-Pacific Lung Cancer Therapeutics Market by Country
6.4. RoW
6.4.1. RoW Lung Cancer Therapeutics Market by Type of Molecule
6.4.2. RoW Lung Cancer Therapeutics Market by Disease Type
6.4.3. RoW Lung Cancer Therapeutics Market by Sub-region
7. Company Covered
7.1. Astellas Pharma
7.2. Pfizer
7.3. Amgen
7.4. Celgene
7.5. Astrazeneca
7.6. F. Hofmann-la Roche
7.7. Glaxosmithkline
7.8. Aetna, Agennix
7.9. Eli Lilly
7.10. Boston Biomedical

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report